La multirésistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992

Translated title of the contribution: Multidrug resistance (MDR) of Mycobacterium tuberculosis in France since 1992

J. Robert, D. Trystram, C. Truffot, J. Grosset

Research output: Contribution to journalArticle

Abstract

Purpose. - Multidrug resistant tuberculosis (MDR-Tb) is a threat to tuberculosis control programmes. Data from MDR-Tb surveillance in France since 1992 are reported. Design. - Annual surveys were performed to collect all culture-positive cases of tuberculosis in France. Information on MDR-Tb cases included age, sex, country of birth, site of Th, HIV co-infection, date of first diagnosis of Tb and drug susceptibility. Results. - The annual prevalence of MDR-Tb cases was 0.6% on average and remained stable during the study period. A majority of MDR-Tb cases were male (70%), foreign-born (56%), and previously treated (66%). HIV co-infection, present in 21% of patients, was associated with primary MDR-Tb. Among MDR-Tb cases, 16% have been notified at least two different years suggesting they remained sources of MDR infection for long. Conclusion. - The low and stable prevalence rate of MDR-Tb reflects the adequate treatment of new cases of tuberculosis in France. However, because 16% of notified MDR-Tb cases remained culture-positive for years, there is room for improved treatment of these cases.

Original languageFrench
JournalMedecine et Maladies Infectieuses
Volume33
Issue numberSUPPL. 3
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Multiple Drug Resistance
Mycobacterium tuberculosis
France
Tuberculosis
Coinfection
HIV Infections
Multidrug-Resistant Tuberculosis
Parturition
Therapeutics
Infection

Keywords

  • Multidrug resistance
  • Mycobacterium tuberculosis
  • Tuberculosis

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

La multirésistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992. / Robert, J.; Trystram, D.; Truffot, C.; Grosset, J.

In: Medecine et Maladies Infectieuses, Vol. 33, No. SUPPL. 3, 01.03.2003.

Research output: Contribution to journalArticle

Robert, J. ; Trystram, D. ; Truffot, C. ; Grosset, J. / La multirésistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992. In: Medecine et Maladies Infectieuses. 2003 ; Vol. 33, No. SUPPL. 3.
@article{7c14d0315d2945eaaf9d028b52f0a042,
title = "La multir{\'e}sistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992",
abstract = "Purpose. - Multidrug resistant tuberculosis (MDR-Tb) is a threat to tuberculosis control programmes. Data from MDR-Tb surveillance in France since 1992 are reported. Design. - Annual surveys were performed to collect all culture-positive cases of tuberculosis in France. Information on MDR-Tb cases included age, sex, country of birth, site of Th, HIV co-infection, date of first diagnosis of Tb and drug susceptibility. Results. - The annual prevalence of MDR-Tb cases was 0.6{\%} on average and remained stable during the study period. A majority of MDR-Tb cases were male (70{\%}), foreign-born (56{\%}), and previously treated (66{\%}). HIV co-infection, present in 21{\%} of patients, was associated with primary MDR-Tb. Among MDR-Tb cases, 16{\%} have been notified at least two different years suggesting they remained sources of MDR infection for long. Conclusion. - The low and stable prevalence rate of MDR-Tb reflects the adequate treatment of new cases of tuberculosis in France. However, because 16{\%} of notified MDR-Tb cases remained culture-positive for years, there is room for improved treatment of these cases.",
keywords = "Multidrug resistance, Mycobacterium tuberculosis, Tuberculosis",
author = "J. Robert and D. Trystram and C. Truffot and J. Grosset",
year = "2003",
month = "3",
day = "1",
language = "French",
volume = "33",
journal = "Medecine et Maladies Infectieuses",
issn = "0399-077X",
publisher = "Elsevier Masson",
number = "SUPPL. 3",

}

TY - JOUR

T1 - La multirésistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992

AU - Robert, J.

AU - Trystram, D.

AU - Truffot, C.

AU - Grosset, J.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Purpose. - Multidrug resistant tuberculosis (MDR-Tb) is a threat to tuberculosis control programmes. Data from MDR-Tb surveillance in France since 1992 are reported. Design. - Annual surveys were performed to collect all culture-positive cases of tuberculosis in France. Information on MDR-Tb cases included age, sex, country of birth, site of Th, HIV co-infection, date of first diagnosis of Tb and drug susceptibility. Results. - The annual prevalence of MDR-Tb cases was 0.6% on average and remained stable during the study period. A majority of MDR-Tb cases were male (70%), foreign-born (56%), and previously treated (66%). HIV co-infection, present in 21% of patients, was associated with primary MDR-Tb. Among MDR-Tb cases, 16% have been notified at least two different years suggesting they remained sources of MDR infection for long. Conclusion. - The low and stable prevalence rate of MDR-Tb reflects the adequate treatment of new cases of tuberculosis in France. However, because 16% of notified MDR-Tb cases remained culture-positive for years, there is room for improved treatment of these cases.

AB - Purpose. - Multidrug resistant tuberculosis (MDR-Tb) is a threat to tuberculosis control programmes. Data from MDR-Tb surveillance in France since 1992 are reported. Design. - Annual surveys were performed to collect all culture-positive cases of tuberculosis in France. Information on MDR-Tb cases included age, sex, country of birth, site of Th, HIV co-infection, date of first diagnosis of Tb and drug susceptibility. Results. - The annual prevalence of MDR-Tb cases was 0.6% on average and remained stable during the study period. A majority of MDR-Tb cases were male (70%), foreign-born (56%), and previously treated (66%). HIV co-infection, present in 21% of patients, was associated with primary MDR-Tb. Among MDR-Tb cases, 16% have been notified at least two different years suggesting they remained sources of MDR infection for long. Conclusion. - The low and stable prevalence rate of MDR-Tb reflects the adequate treatment of new cases of tuberculosis in France. However, because 16% of notified MDR-Tb cases remained culture-positive for years, there is room for improved treatment of these cases.

KW - Multidrug resistance

KW - Mycobacterium tuberculosis

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0037358182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037358182&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0037358182

VL - 33

JO - Medecine et Maladies Infectieuses

JF - Medecine et Maladies Infectieuses

SN - 0399-077X

IS - SUPPL. 3

ER -